Insights Into $3.72B Clinical Trial Supplies Market By 2028
The market for clinical trial supplies has shown strong growth recently, expanding from $2.52 billion in 2023 to $2.75 billion in 2024, with a...
New FDA Guidance To Enhance Diversity In Clinical Trials
The FDA has made progress in promoting diversity in clinical trials. Recently, the agency published a draft guidance providing more information on how sponsors...
Great Point Partners Acquires Lyocontract – A German CDMO
On a mission so as to debut the life sciences companies on an international stage, Great Point Partners, the healthcare investment firm, is making...
Transforming In 2024 & Beyond – Prefilled Syringes Market
Prefilled syringes have gone on to make up a decent portion in terms of injectable packaging segment in the past 10 years. As per...
Role of Innovation In The Rise of Prefilled Biologics Space
It is well to be noted that prefilled products, specifically prefilled biologics, happen to be a growing segment in the pharmaceutical sector. Prefilled syringes...
Major Surge Expected In The Injectable Drug Delivery Market
A new report rolled out by MarketsandMarkets has gone on to forecast that the injectable drug delivery market is going to be reaching almost...
World-Class Biopharma Production Offered By APAC Bioclusters
Worldwide pharmaceutical companies look to advance the development of molecules from the laboratory to the clinic and then market them as soon as possible....
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...